November 27, 2019
Some of the nation's biggest school districts are suing major drug companies over student learning disabilities and other problems allegedly linked to the opioid crisis, portending a potentially enormous new front in the multidistrict opioid litigation.
November 19, 2019
The Ohio federal judge guiding multidistrict opioid litigation on Tuesday singled out numerous cases as good candidates for future bellwether trials, pitting a potpourri of plaintiffs against an assortment of drug companies.
November 07, 2019
The Ohio federal judge supervising multidistrict opioid litigation has warned attorneys for local governments and drug companies that he will unilaterally select future bellwether trials unless they quickly do so themselves, according to a meeting transcript obtained Thursday by Law360.
November 05, 2019
The Ohio federal judge overseeing multidistrict opioid litigation appears to have decided key issues about the MDL's future without first accepting input from pharmacy defendants, according to their strongly worded court filing late Tuesday.
October 31, 2019
Attorneys in the opioid multidistrict litigation are gearing up for a closed-door debate next week over future bellwether trials, a showdown that will closely follow settlements that canceled the MDL's first trial.
October 21, 2019
A rapid outburst of opposition to a $48 billion "settlement framework" in opioid-crisis litigation unveiled Monday by four state attorneys general may signal a shift to local governments and states fighting not only with drug companies but also with each other.
October 21, 2019
Four attorneys general on Monday unveiled a proposed $48 billion deal with major drug companies — Teva Pharmaceuticals, Johnson & Johnson and the nation's largest drug distributors — to resolve a wave of opioid-crisis lawsuits.
October 21, 2019
Two Ohio counties on Monday reached a deal worth $260 million with some of the nation's largest drug companies to avoid the first trial in opioid multidistrict litigation.
October 17, 2019
Amid whirlwind settlement talks, nationwide litigation over the pharmaceutical industry’s alleged role in the opioid crisis is on the cusp of a historic trial. Here, Law360 looks at settlement prospects and key issues if the epic courtroom showdown proceeds.
October 16, 2019
Major drug manufacturers and distributors — including Johnson & Johnson and McKesson — are proposing deals that could be worth a combined $50 billion to resolve large portions of nationwide litigation over pharmaceutical industry liability for the opioid crisis, a source with direct knowledge of the offers told Law360 on Wednesday.